Brain Health Support Program
Dementia Prevention · Mild Cognitive Impairment · Subjective Cognitive Impairment · Cognitive Change
Bottom Line
View on ClinicalTrials.gov: NCT05347966 ↗Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Brain Health PRO (Other)
- Age
- Adult, Older Adult · 60+ yrs
- Sex
- All
- Sponsor
- Baycrest
- Primary completion
- Jan 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Dementia Literacy From Baseline to Month 12 |
0.191 | — |
| SECONDARY Change in Self-efficacy From Baseline to Month 12 |
0.157 | — |
| SECONDARY To Evaluate Usability of BHPro |
34 | — |
| SECONDARY Number of Chapters Completed on BHPro |
142 | — |
| SECONDARY To Evaluate User Acceptance of BHPro With the Technology Acceptance Model Questionnaire (TAMQ). |
94 | — |
Summary
Eligibility Criteria
Inclusion Criteria
- Completion and documentation of the electronic Informed Consent Process (from the participant)
- Sufficient proficiency in English or French to undergo remote clinical and neuropsychological assessment and participate in an online educational program.
- Technical ability to participate in an online educational program and remote assessments (i.e. computer and internet access; ability to send and receive emails; ability to complete remote assessments)
- Sufficient vision and hearing to participate in online educational program and to undergo remote clinical and neuropsychological testing
- Ability to sit comfortably for a period of about 30 minutes
- Ages 60-85
- Meets criteria for No Dementia and meet criteria [according to Canadian Consortium on Neurodegeneration in Aging (CCNA) Criteria, Appendix 1] of one of the following:
- Cognitively Unimpaired (CU)
- Cognitively Unimpaired plus Subjective Cognitive Impairment (CU + SCI)
- Mild Cognitive Impairment (MCI)
- AND Classified as being at increased risk of dementia based on at least one of the following:
- First-degree family history of dementia
- Self-Reported or documented current and/or history at midlife (45-60 years) on any of the following lifestyle risk factors:
Hypertension (documented Systolic Blood Pressure > 140 mm Hg; OR physician diagnosis of hypertension; OR treatment for hypertension; OR other approaches to treatment (e.g. diet, exercise)) Hypercholesterolemia (documented total cholesterol > 6.5 mmol/L; OR physician diagnosis of hypercholesterolemia; OR treatment for hypercholesterolemia; OR other approaches to treatment (e.g. diet, exercise) Body Mass Index > 30 kg/m2 (derived from NIH Metric BMI Calculator) Physical Inactivity (active is defined as engaging in a minimum of 20- 30 min of physical activity causing sweating and breathlessness, at least 2 times a week)
- Participant has a family physician or other healthcare provider and agrees to have the provider notified of participation in the study and incidental or other findings that may be clinically significant
Exclusion Criteria
- Participants who, in the opinion of the investigator, are not able to complete trial procedures remotely or adhere to the schedule of study assessments will be excluded from study participation.
- Individuals where English or French is not sufficiently proficient for remote clinical assessment, neuropsychological testing and participation in an online educational program.
- Participants who do not have sufficient vision and hearing for remote clinical assessment, neuropsychological testing participation in an online educational program
- Individuals who do not have the technical ability to participate in an online educational program. Technical ability is defined as having computer and internet access; ability to send and receive emails; ability to participate in remote assessments
- Individuals who have a clinical diagnosis of Dementia
- Clinical Dementia Rating (CDR; telephone/video-conference administration) Score of >1
- Total Score on the Montreal Cognitive Assessment (MoCA; video-conference administration) <13
Data sourced from ClinicalTrials.gov (NCT05347966). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.